← Leaderboards
James M Hill
Louisiana State Univ Hsc New Orleans
$6,826,937
Attributed
$6,826,937
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $757.3K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$6,826,937 · 5
By mechanism
R01$6,129,281 · 3
P30$697,656 · 2
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ Hsc New Orleans
Same institution · by research overlap
- Herbert E Kaufman$3,559,218
- William Guido$9,794,981
- Mary E Marquart$2,873,558
- David H. Martin$5,023,904
- Richard Joseph O'Callaghan$5,455,486
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionVisionLaboratory RabbitPolymerase Chain ReactionVirusTissuesRelapse /RecurrenceHerpes Simplex Virus 1Immediate Early ProteinLaboratory MouseVirus DnaHost Organism InteractionHerpesvirus 1, HumanRecurrent DiseaseHyperthermiaRelating To Nervous SystemNeuronsLatent Virus InfectionImmunocytochemistryLesionNontherapeutic IontophoresisGenetic Promoter ElementCharacteristicsExhibits
Grant awards (29)
Ocular HSV-Latency, Reactivation, and Recurrence$93,204
R01 · FY2012 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$420,772
R01 · FY2011 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$422,230
R01 · FY2010 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$424,550
R01 · FY2009 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$387,740
R01 · FY2008 · EY · contact PI
CELLULAR & MOLECULAR BIOLOGY$131,542
P30 · FY2008 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$447,219
R01 · FY2007 · EY · contact PI
Aging, Herpesviruses, and Alzheimer's Disease$165,610
R01 · FY2007 · AG · contact PI
CELLULAR & MOLECULAR BIOLOGY$144,461
P30 · FY2007 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$436,945
R01 · FY2006 · EY · contact PI
Aging, Herpesviruses, and Alzheimer's Disease$170,556
R01 · FY2006 · AG · contact PI
CELLULAR & MOLECULAR BIOLOGY$59,686
P30 · FY2006 · EY · contact PI
Ocular HSV-Latency, Reactivation, and Recurrence$456,563
R01 · FY2005 · EY
Aging, Herpesviruses, and Alzheimer's Disease$175,685
R01 · FY2005 · AG
CELLULAR &MOLECULAR BIOLOGY$61,077
P30 · FY2005 · EY
Ocular HSV--Latency, Reactivation, and Recurrence$387,070
R01 · FY2004 · EY
Aging, Herpesviruses, and Alzheimer's Disease$175,890
R01 · FY2004 · AG
Ocular HSV--Latency, Reactivation, and Recurrence$95,810
R01 · FY2004 · EY
CELLULAR &MOLECULAR BIOLOGY$70,931
P30 · FY2004 · EY
Ocular HSV--Latency, Reactivation, and Recurrence$387,070
R01 · FY2003 · EY
Ocular HSV--Latency, Reactivation, and Recurrence$387,224
R01 · FY2002 · EY
CORE--CULTURE (VIRUSES, BACTERIA, PLASMIDS, AND CELLS)$131,647
P30 · FY2002 · EY
OCULAR PATHOGENESIS AND THERAPY OF BACTERIAL KERATITIS$301,534
R01 · FY2001 · EY
Ocular HSV--Latency, Reactivation, and Recurrence$160,875
R01 · FY2001 · EY
OCULAR HSV--LATENCY, REACTIVATION, AND RECURRENCE$121,399
R01 · FY2001 · EY
CORE--CULTURE (VIRUSES, BACTERIA, PLASMIDS, AND CELLS)$0
P30 · FY2001 · EY
OCULAR PATHOGENESIS AND THERAPY OF BACTERIAL KERATITIS$286,084
R01 · FY2000 · EY
OCULAR HSV--LATENCY, REACTIVATION, AND RECURRENCE$225,251
R01 · FY2000 · EY
CORE--CULTURE (VIRUSES, BACTERIA, PLASMIDS, AND CELLS)$98,312
P30 · FY2000 · EY